Terms: = Breast cancer AND WAS, P42768, 7454, ENSG00000015285, WASP, THC, IMD2 AND Treatment
37 results:
1. Efficacy and mechanisms of cannabis oil for alleviating side effects of breast cancer chemotherapy (CBC2): protocol for randomized controlled trial.
Thu MS; Pongpirul K; Vongsaisuwon M; Vinayanuwattikun C; Banchuen K; Ondee T; Payungporn S; Phutrakool P; Nootim P; Chariyavilaskul P; Cherdchom S; Wanaratna K; Hirankarn N
BMC Complement Med Ther; 2024 Mar; 24(1):130. PubMed ID: 38521934
[TBL] [Abstract] [Full Text] [Related]
2. Associations between lifestyle, health, and clinical characteristics and circulating oxysterols and cholesterol precursors in women diagnosed with breast cancer: a cross-sectional study.
Decker NS; Johnson T; Le Cornet C; Behrens S; Obi N; Kaaks R; Chang-Claude J; Fortner RT
Sci Rep; 2024 Feb; 14(1):4977. PubMed ID: 38424253
[TBL] [Abstract] [Full Text] [Related]
3. Cannabidiol Combination Enhances Photodynamic Therapy Effects on MCF-7 breast cancer Cells.
Mokoena D; George BP; Abrahamse H
Cells; 2024 Jan; 13(2):. PubMed ID: 38247877
[No Abstract] [Full Text] [Related]
4. The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results.
Rugo HS; Im SA; Joy AA; Shparyk Y; Walshe JM; Sleckman B; Loi S; Theall KP; Kim S; Huang X; Bananis E; Mahtani R; Finn RS; Diéras V
Future Oncol; 2024 Jan; 20(1):5-16. PubMed ID: 37916267
[TBL] [Abstract] [Full Text] [Related]
5. Phytocannabinoids in Triple Negative breast cancer treatment: Current Knowledge and Future Insights.
Bimonte S; Palma G; Cascella M; Cuomo A
Anticancer Res; 2023 Mar; 43(3):993-1000. PubMed ID: 36854495
[TBL] [Abstract] [Full Text] [Related]
6. Antitumoral potential of Chartergellus-CP1 peptide from Chartergellus communis wasp venom in two different breast cancer cell lines (HR+ and triple-negative).
Soares S; Lopes KS; Mortari M; Oliveira H; Bastos V
Toxicon; 2022 Sep; 216():148-156. PubMed ID: 35839869
[TBL] [Abstract] [Full Text] [Related]
7. 2',3',4'-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism.
Herber CB; Yuan C; Chang A; Wang JC; Cohen I; Leitman DC
Mol Med; 2022 Apr; 28(1):44. PubMed ID: 35468719
[TBL] [Abstract] [Full Text] [Related]
8. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
Truong TH; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Muangnoi C; Nalinratana N; Vajragupta O; Rojsitthisak P; Rojsitthisak P
Carbohydr Polym; 2022 Jul; 288():119401. PubMed ID: 35450653
[TBL] [Abstract] [Full Text] [Related]
9. Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey.
Vandraas K; Falk RS; Bøhn SKH; Kiserud C; Lie HC; Smedsland SK; Ewertz M; Dahl S; Brekke M; Reinertsen KV
Breast Cancer Res Treat; 2022 Jun; 193(3):685-694. PubMed ID: 35445949
[TBL] [Abstract] [Full Text] [Related]
10. Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in breast cancer Cells.
Salbini M; Quarta A; Russo F; Giudetti AM; Citti C; Cannazza G; Gigli G; Vergara D; Gaballo A
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577048
[TBL] [Abstract] [Full Text] [Related]
11. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
Yang Y; Zhu Y; Li X; Zhang X; Yu B
Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
[TBL] [Abstract] [Full Text] [Related]
12. Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.
Wang J; Li Z; Yin F; Zhang R; Zhang Y; Wang Z; Sheng X
Cancer Gene Ther; 2022 Mar; 29(3-4):253-263. PubMed ID: 33742130
[TBL] [Abstract] [Full Text] [Related]
13. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract] [Full Text] [Related]
14. Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies.
Bachari A; Piva TJ; Salami SA; Jamshidi N; Mantri N
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839414
[TBL] [Abstract] [Full Text] [Related]
15. Marijuana Use for Women: To Prescribe or Not to Prescribe.
Huang L; Zhang X; Xu A
Subst Use Misuse; 2020; 55(12):2076-2077. PubMed ID: 32627638
[TBL] [Abstract] [Full Text] [Related]
16. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
[TBL] [Abstract] [Full Text] [Related]
17. Future Aspects for Cannabinoids in breast cancer Therapy.
Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
[TBL] [Abstract] [Full Text] [Related]
18. Therapeutic targeting of HER2-CB
Blasco-Benito S; Moreno E; Seijo-Vila M; Tundidor I; Andradas C; Caffarel MM; Caro-Villalobos M; Urigüen L; Diez-Alarcia R; Moreno-Bueno G; Hernández L; Manso L; Homar-Ruano P; McCormick PJ; Bibic L; Bernadó-Morales C; Arribas J; Canals M; Casadó V; Canela EI; Guzmán M; Pérez-Gómez E; Sánchez C
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3863-3872. PubMed ID: 30733293
[TBL] [Abstract] [Full Text] [Related]
19.
Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
[TBL] [Abstract] [Full Text] [Related]
20. Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.
Hilchie AL; Sharon AJ; Haney EF; Hoskin DW; Bally MB; Franco OL; Corcoran JA; Hancock REW
Biochim Biophys Acta; 2016 Dec; 1858(12):3195-3204. PubMed ID: 27693190
[TBL] [Abstract] [Full Text] [Related]
[Next]
